139 related articles for article (PubMed ID: 717508)
21. Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation.
Saari KM; Nelimarkka L; Ahola V; Loftsson T; Stefánsson E
Graefes Arch Clin Exp Ophthalmol; 2006 May; 244(5):620-6. PubMed ID: 16217662
[TBL] [Abstract][Full Text] [Related]
22. Topical treatment of experimental acute corneal inflammation by dexamethasone and nonsteroidal drugs.
Alio JL; Ayala MJ; Mulet ME; Artola A; Ruiz JM
Ophthalmic Res; 1994; 26(2):87-94. PubMed ID: 8196937
[TBL] [Abstract][Full Text] [Related]
23. Periocular injection of corticosteroids: an experimental evaluation of its role in the treatment of corneal inflammation.
Leibowitz HM; Kupferman A
Arch Ophthalmol; 1977 Feb; 95(2):311-4. PubMed ID: 836214
[TBL] [Abstract][Full Text] [Related]
24. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
[TBL] [Abstract][Full Text] [Related]
25. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits.
Schoenwald RD; Stewart P
J Pharm Sci; 1980 Apr; 69(4):391-4. PubMed ID: 7373531
[TBL] [Abstract][Full Text] [Related]
26. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
Fukuda M; Inoue A; Sasaki K; Takahashi N
Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of topically administered prednisolone acetate. Optimal concentration for treatment of inflammatory keratitis.
Leibowitz HM; Kupferman A
Arch Ophthalmol; 1976 Aug; 94(8):1387-9. PubMed ID: 949281
[TBL] [Abstract][Full Text] [Related]
28. Aqueous humor alkalosis and marked reduction in ocular ascorbic acid content following long-term topical cortisone (9alpha-fluoro-16alpha-methylprednisolone).
Virno M; Schirru A; Pecori-Giraldi J; Pellegrino N
Ann Ophthalmol; 1974 Oct; 6(10):983-6, 989-92. PubMed ID: 4429318
[No Abstract] [Full Text] [Related]
29. Detection of dexamethasone in the cornea and lens by NMR spectroscopy.
Midelfart A; Dybdahl A; Krane J
Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):415-23. PubMed ID: 10333109
[TBL] [Abstract][Full Text] [Related]
30. Collagen shield enhancement of topical dexamethasone penetration.
Hwang DG; Stern WH; Hwang PH; MacGowan-Smith LA
Arch Ophthalmol; 1989 Sep; 107(9):1375-80. PubMed ID: 2783071
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of the effects of 0.1% bromfenac sodium eye drops and corticosteroids after small incision lenticule extraction].
Jiang Y; Li Y; Jin YM; Zhang JY
Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):18-22. PubMed ID: 28162195
[No Abstract] [Full Text] [Related]
32. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
33. Enhanced acute ocular hypotensive response to timolol with dexamethasone treatment.
Rom M; Schwartz B; Bealka N
J Glaucoma; 1997 Apr; 6(2):111-6. PubMed ID: 9098819
[TBL] [Abstract][Full Text] [Related]
34. Topical fluconazole for experimental candida keratitis in rabbits.
Behrens-Baumann W; Klinge B; Rüchel R
Br J Ophthalmol; 1990 Jan; 74(1):40-2. PubMed ID: 2306443
[TBL] [Abstract][Full Text] [Related]
35. [Effect of corticosteroids in antimycotic therapy of Candida keratitis].
Behrens-Baumann W; Küster M
Klin Monbl Augenheilkd; 1987 Sep; 191(3):222-5. PubMed ID: 3682686
[TBL] [Abstract][Full Text] [Related]
36. Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension.
Scoper SV; Kabat AG; Owen GR; Stroman DW; Kabra BP; Faulkner R; Kulshreshtha AK; Rusk C; Bell B; Jamison T; Bernal-Perez LF; Brooks AC; Nguyen VA
Adv Ther; 2008 Feb; 25(2):77-88. PubMed ID: 18309465
[TBL] [Abstract][Full Text] [Related]
37. Comparative anti-inflammatory efficacy of topical corticosteroids with low glaucoma-inducing potential.
Leibowitz HM; Ryan WJ; Kupferman A
Arch Ophthalmol; 1992 Jan; 110(1):118-20. PubMed ID: 1731703
[TBL] [Abstract][Full Text] [Related]
38. Fluorometholone acetate. A new ophthalmic derivative of fluorometholone.
Kupferman A; Berrospi AR; Leibowitz HM
Arch Ophthalmol; 1982 Apr; 100(4):640-1. PubMed ID: 7073584
[TBL] [Abstract][Full Text] [Related]
39. A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits.
Bodor N; Bodor N; Wu WM
Curr Eye Res; 1992 Jun; 11(6):525-30. PubMed ID: 1505197
[TBL] [Abstract][Full Text] [Related]
40. Comparison of ophthalmic bioavailability of two dexamethasone derivatives in proprietary preparations.
Morton DJ; Flint GR
Cent Afr J Med; 1985 Feb; 31(2):32-4. PubMed ID: 3839168
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
